Amicus Therapeutics to Present at 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – CRANBURY, N.J., Jan. 2, 2013 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that … more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard

See who Amicus is hiring next, click here to view